Arbor Pharmaceuticals, Inc.
11 drugs in NADAC|11 Generic,0 Brand
Arbor Pharmaceuticals, Inc. lists 11 NDCs in the CMS NADAC file (11 generic, 0 brand), at an average NADAC of $3.64 per unit, with a week-over-week move of -2.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
11
11G / 0B
Avg Price / Unit
$3.6368
$1.90 – $8.52
Avg 7d Change
-1.96%
Across 4 drugs with changes
7d Activity
of 11 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Erythromycin market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Macrolide Antimicrobial therapeutic class
Review the broader class where Arbor Pharmaceuticals, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Arbor Pharmaceuticals, Inc. make?
Arbor Pharmaceuticals, Inc. lists 11 NDCs in the CMS NADAC file — 11 generic and 0 brand products.
What is the average price of Arbor Pharmaceuticals, Inc. drugs?
The average NADAC across Arbor Pharmaceuticals, Inc.'s portfolio is $3.6368 per unit, ranging from $1.9029 to $8.5150.
What types of drugs does Arbor Pharmaceuticals, Inc. make?
Arbor Pharmaceuticals, Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Macrolide Antimicrobial (11), Macrolide (11).
Has Arbor Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Arbor Pharmaceuticals, Inc. in the openFDA feed.
How has Arbor Pharmaceuticals, Inc.'s pricing changed recently?
Over the past 7 days, 2 Arbor Pharmaceuticals, Inc. products rose and 2 fell, with a portfolio-wide average change of -2.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ERY-TAB DR 333 MG TABLET Erythromycin | $8.5150 per EA | — |
ERY-TAB DR 500 MG TABLET Erythromycin | $4.8465 per EA | — |
ERYTHROMYCIN DR 250 MG CAP Erythromycin | $4.8072 per EA | — |
ERY-TAB DR 250 MG TABLET Erythromycin | $3.8591 per EA | — |
ERY-TAB DR 333 MG TABLET Erythromycin | $3.2578 per EA | -9.07% |
ERY-TAB DR 500 MG TABLET Erythromycin | $3.1144 per EA | +5.08% |
ERYTHROMYCIN 500 MG TABLET Erythromycin | $3.0014 per EA | — |
ERYTHROMYCIN 500 MG TABLET Erythromycin | $2.8197 per EA | — |
ERYTHROMYCIN 250 MG TABLET Erythromycin | $1.9552 per EA | +3.83% |
ERY-TAB DR 250 MG TABLET Erythromycin | $1.9250 per EA | -7.66% |
ERYTHROMYCIN 250 MG TABLET Erythromycin | $1.9028 per EA | — |